immobilization hypercalemia

17
Immobilization Hypercalcemia Andrew N. Antonio, OTS University of St. Augustine

Upload: andrew-antonio-otrl

Post on 17-Aug-2015

36 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Immobilization Hypercalemia

Immobilization HypercalcemiaAndrew N. Antonio, OTSUniversity of St. Augustine

Page 2: Immobilization Hypercalemia

OverviewDefinitionEtiology and pathophysiologyCharacterize the condition as it

relates SCIProsed ManagementCase ReviewQuestions

Page 3: Immobilization Hypercalemia

Hypercalcemia

“Hypercalemia results when the accelerated bone resorption exceeds the capacity of the kidneys to filter calcium.”

Massagli & Cardenas, 1999

Page 4: Immobilization Hypercalemia

CalciumRegulation and processes of body

functionsRegulation

◦Parathyroid hormone (PTH)◦Vitamin D◦Calcitonin

Page 5: Immobilization Hypercalemia

HypercalcemiaMild (Ca+ <12 mg/dl)Moderate (Ca+ between 12 and

14 mg/dl)Severe (Ca+ >14 mg/dl)

Diagnosed via blood test

Page 6: Immobilization Hypercalemia

EtiologyMain cause is hyperparathyroidism

(>90%)◦Common in women over 50 y/o

Malignancies may be associated (20%)Inherited kidney or metabolic

conditionsExcessive Vitamin D & AAluminum intoxicationMilk-Alkali SyndromeImmobilization

Page 7: Immobilization Hypercalemia

Immobilization Hypercalcemia

Acute spinal cord injury (10-23%)Often in male adolescents/ young

adultsTetraplegia v. paraplegiaIncrease bone resorptionLoss of trabecular bone volumeDecreased osteoblastic bone

formationDepressed parathyroid hormone

Page 8: Immobilization Hypercalemia

Immobilization Hypercalcemia cont.Develops within days to months of

immobilization~4 - 8 weeks after

Last weeks to monthsHypercalciuria

◦Within 1st week up to 6-18 months

Page 9: Immobilization Hypercalemia

Signs and SymptomsFatigueConstipationAnorexiaNauseaAlteration in moodVomitingLethargyPolydipsiaPolyuria Intravascular volume depletionHypertensionArrythmias

Page 10: Immobilization Hypercalemia

TreatmentGoal:

◦ Decrease serum Ca+ concentration◦ Underlying disease

HydrationLoop Diuretics (i.e. furosemide)BiphosphonatesAntineoplastic DrugsAntidote, hypercalcemia agentsGlucocorticoidsMineralsCalcimimetic AgentSurgical treatment

Massagli & Cardenas, 1999

Page 11: Immobilization Hypercalemia

Zoledronic Acid Biphosphonate Ca+ Regulator Reduces risk for Fx Once-yearly injection 100-850 times more potent than Pamidronate Paget’s disease, osteoporosis Side effects

◦ Flu-like symptoms (within 3 days)◦ Fever◦ Headache◦ Muscle spasm◦ Severe muscle, joint or bone pain◦ Decrease urination level and frequency◦ Hypertension◦ *Jaw problems

Page 12: Immobilization Hypercalemia

Rehabilitation Team“Moans”, “Stones”, “Groans” &

“Bones”Early RemobilizationActive movementWeight bearingUpdate on medical statusIncrease fluid intakePatient/ family/ caregiver

education Massagli & Cardenas, 1999

Page 13: Immobilization Hypercalemia

Crown et al. American Journal of Clinical Medicine, 2009

46 y/o female Stopped by airport police for erratic Bx Hx of hypertension, alcohol abuse, Hep B Presenting symptoms: generalized confusion, lethargy,

hypertension Physical exam unremarkable with no focal motor or sensory

deficits, cont. altered mental status Progressed to abdominal pain, severe constipation,

bradycardia, electrolyte imbalance

Findings: Altered state & acute pancreatitis due to hypercalcemia Hypomagnesia & acute renal failure due to dehydration

Page 14: Immobilization Hypercalemia

Massagli et al. Arch Phys Med Rehabilitation, 1999

9 patients with immobilization

hypercalcemia◦7 men, 2 women◦Mean age 22 y/o◦Onset ranged from 3 – 16 weeks

Pamidronate DisodiumEffectiveness, duration of Tx, and ease of

administration appear promisingLess interruption of activities Excellent response, with few complicationsOf 78% of the pts., only one treatment

needed

Page 15: Immobilization Hypercalemia

SummaryAcute SCIDifficult to detect early More in male adolescents and

younger adultsVarying levels of severityCannot be preventedAim to restore Ca+ levels, and treat

underlying diseaseMobilization and weight bearingMedications or injection

Page 16: Immobilization Hypercalemia

ReferencesAgrharkar, M. (2014). Hypercalcemia Medication. Retrieved

December 5, 2014, from http://emedicine.medscape.com/

American Occupational Therapy Association. (2008). Occupational therapy practice framework: Domain and process (2nd ed.). American Journal of Occupational Therapy, 62, 625-683.

Crown et. al. (2009) Hypercalcemic crisis: a case study. American Journal of Clinical Rehabilitation. 6(1), 38-40.

Kolnick et. al (2011). Hypercalcemia in Pregnancy: A case of milk-alkali syndrome. Retrieved December 1, 2014 from http:// ncbi.nlm.nih.gov/

Massagli, T. & Cardenas, D. (1999) Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury. Arch Phys Med Rehabilitation. 80(2), 998-1000

Shane, E. & Berenson, J. (2014). Treatment of Hypercalcemia. Retrieved December 4, 2014, from http://uptodate.com/

Zoldronic Acid (Injection). (2014). Retrieved December 16, 2014, from https://www.ncbi.nlm.nih.gov/pubmedhealth/

Page 17: Immobilization Hypercalemia

Questions?